HHT Centers of Excellences across the U.S. are now enrolling patients to participate in the new randomized clinical trial to assess the effectiveness of Pazopanib in reducing the severity of nose bleeds in adults with HHT.
To learn more about the trial and to understand if participation may be right for you, please visit the clinical trials section of our website.
By participating in clinical research, you can play a role in helping the development of new treatments and therapeutics – which have the potential to lead to a higher quality of life for generations of HHT patients.Read More
The 14th HHT International Scientific Conference brought together 300 in-person attendees and 50 virtual viewers to present and discuss the most recent and impactful scientific and clinical advances in HHT.
The meeting had a record number of 209 original research abstracts submitted and the top scoring abstracts were selected for oral presentations. The Executive Summary and Abstract Summary published in Angiogenesis highlight the high-caliber HHT research presented in Portugal from trainees, scientists, and clinicians around the world.Read More
Cleveland Clinic – “Every time Lindsay Vos got a throbbing headache, or felt weakness on the left side of…Read More
Much of HHT education comes from the deeply personal stories of those who are living with the disorder. This…Read More
Podcast Series | The Department of Medicine at the University of North Carolina Check out the transcript of a…Read More
Book Review | Journal of Radiology Nursing June 2018: Volume 37, Issue 2, Page 137. Read the article from…Read More
Fox 45 News Baltimore | June 18, 2018 Check out the news clip from the interview between Fox 45…Read More